Meril Diagnostics Private LimitedS1.G30Meril Diagnostics, founded in 2013 in Vapi, India, is a global leader in medical diagnostics. Operating from the 180-acre Meril Park with a 300,000 sq. ft. cGMP-certified facility, the company fulfills its mission to alleviate human suffering through its philosophy: "Research empowering Individual and Learning."
With a presence in 158 countries and 35 subsidiaries, Meril supports 20,000 users and an instrument base of 25,000. Its multidisciplinary team of 13,000 employees and 400 specialized R&D experts drives innovation across more than 250 products.
Core Product Portfolios:
1. Clinical Chemistry (Merilyzer): From the semi-automated CliniQuant with its 32µl flow cell to the high-throughput AutoQuant 400 (400 tests/hr), Meril provides scalable solutions for labs of all sizes. The AutoQuant 100 and 200 series emphasize efficiency with low water consumption and refrigerated reagent storage.
2. Hematology (CelQuant): The range includes 3-part and 5-part analyzers. The CelQuant 3 offers 21 parameters and 500,000-result storage, while the CelQuant 5 Ultima utilizes advanced LASER scattering and flow cytometry for precise cell differentiation.
3. ELISA & Immunology: The EIAQuant reader features an 8-channel fiber optics system for high-speed reading, paired with the EIAWash, which minimizes cross-contamination through flexible washing protocols.
4. Rapid & Self-Testing: We offers rapid kits for infectious diseases (Hepatitis, HIV, Syphilis) and vector-borne illnesses (Malaria). Our "Find" range empowers personal health through self-tests for HIV (HIVFIND), pregnancy (EzeeFind), and ovulation (OvuFind), all maintaining high sensitivity and CE certification.
5. Training & Support: Through 12 global academies, Meril prioritizes doctor education and technician training, ensuring that cutting-edge technology leads to precise clinical outcomes.
Meril continues to bridge the gap between advanced technology and affordability, ensuring that "Correct Diagnosis" remains the foundation for effective global healthcare.
